Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious hematologic diseases [3] - The company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 [1] - A live webcast of the presentation will be available on the company's investor relations website [2] Company Overview - Disc Medicine is dedicated to discovering and commercializing novel treatments targeting red blood cell biology, specifically heme biosynthesis and iron homeostasis [3] - The company aims to build a portfolio of innovative, potentially first-in-class therapeutic candidates for a wide spectrum of hematologic diseases [3]